Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Tax Provisions data on file, last reported at $2000.0 in Q2 2025.

• On a quarterly basis, Tax Provisions changed 0.0% year-over-year to $2000.0 in Q2 2025; TTM through Dec 2025 was $2000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2000.0, changed 0.0% from the prior year.
• Tax Provisions for Q2 2025 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
• Over the last five years, Tax Provisions for INBX reached as high as $5000.0 in Q2 2023 and fell as low as -$4000.0 in Q4 2023.
• Historically, Tax Provisions has averaged $1400.0 across 3 years, with a median of $2000.0 in 2023.
• Across the five-year window, Tax Provisions slumped 60.0% in 2024 and changed 0.0% in 2025, its largest moves.
• Year by year, Tax Provisions stood at -$4000.0 in 2023, then surged by 150.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
• Per Business Quant data, the three most recent Tax Provisions figures were $2000.0 in Q2 2025, $2000.0 in Q2 2024, and -$4000.0 in Q4 2023.